Oddbods take a look at everyday life through the eyes of seven distinct personalities, all bundled up in bright furry suits. With an appetite for love, laughter, destruction and drama, prepare ...

2019年5月22日 · According to Aerpio Pharmaceuticals (ARPO) website, they are a bio pharmaceutical company focused on advancing first-in-class treatments for ocular diseases.

2020年1月8日 · CINCINNATI-- (BUSINESS WIRE)--Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to …

2020年12月11日 · Aerpio Pharmaceuticals, Inc. (Aerpio) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and …

2020年12月11日 · The change from baseline in diurnal mean IOP at Day 28 of study eyes treated with razuprotafib BID plus latanoprost showed a statistically significant improvement compared …

2019年3月18日 · AKB-9778 is being developed as a subcutaneous injection for the treatment of non-proliferative diabetic retinopathy and as an eyedrop formulation for the treatment of …

Robot Arpo is an unused and prototype concept of CGI series with same name, which lasted its planning between 2006 until 2010; later used for Hancom Typing Training 2010[1]. The …

2020年12月14日 · Aerpio Pharma (NASDAQ:ARPO) reported positive topline results from its Phase 2 trial evaluating razuprotafib for the treatment of elevated intraocular pressure (IOP). …

Feb. 7, 2020 23:20 UTC Data presented at the 9 th Annual Glaucoma 360 New Horizons Forum CINCINNATI--( BUSINESS WIRE )-- Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a …

2020年8月24日 · Aerpio Pharmaceuticals Inc (NASDAQ:ARPO) commenced the Phase 2 clinical trial of Razuprotafib to evaluate its potential to treat patients with Ocular Hypertension and …